Vimarsana
Biggest News Aggregation in the World

Page 2 - Flanders Future Techfund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Flanders Future Techfund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Flanders Future Techfund Today - Breaking & Trending Today

AstriVax Receives €2.5M Grant - Vimarsana News

AstriVax Receives €2.5M Grant

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

AstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development - Vimarsana News

AstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development

Emmanuel Hanon, PhD, will chair the company's scientific advisory board. Professor Peter Piot (MD, PhD) and Professor Patrick Soentjens (MD, PhD) have been appointed as advisors. Together, they bring complementary

Dr. Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax - Vimarsana News

Dr. Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax

Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company. Last month,

Dr. Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax - Vimarsana News

Dr. Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax

Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company.Last month, AstriVax closed its funding round - led by

KU Leuven spin-off AstriVax raises € 30 million seed capital to build vaccine platform - Vimarsana News

KU Leuven spin-off AstriVax raises € 30 million seed capital to build vaccine platform

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com